Med-tech firms raising money in public or private financings, including: Labcorp, Neo Medical.

Biopharmas in Asia-Pacific raising money in public or private financings: Base Therapeutics.

Biopharmas raising money in public or private financings, including: Base, Centessa, Inmune, Terns, Valneva, Xencor.

Med-tech firms raising money in public or private financings, including: Eclinical Solutions, Owlet.

Three biopharmas debuted on Nasdaq Sept. 13, raising a combined $703 million for two Massachusetts-based companies focused on bifunctional antibodies for autoimmune diseases and cancer, and one Midwestern firm developing peptide therapies for endocrine and metabolic disorders.

Imcheck Therapeutics SAS’s gamma-delta T-cell activating antibody has become a poster child for the French government’s plan to reduce dependence on imports of biopharmaceuticals by directly supporting domestic development and manufacture of 20 novel products by 2030. The Marseille-based company has been awarded nondilutive public funding of €20.18 million (US$22.4 million) as part of the €54 billion France 2030 strategy, which aims to restore the country’s industrial competitiveness.

Biopharmas raising money in public or private financings, including: Aprinoia, Biovaxys, F2G, Oruka, Pila, Summit, Viridian.

Med-tech firms raising money in public or private financings, including: GT Medical Technologies, Owlet, Pathpresenter, Tenon Medical.